Jul 21, 2017
The UK's proposed Accelerated Access Review is being dogged by delay and disappointment, writes Leela Barham.
Jul 19, 2017
Pharmaceutical Executive
Dogs and kids both spontaneously develop a number of cancers, making it a no-brainer for those on both sides of the disease to work together in finding new therapies.
Jul 19, 2017
A recent IT leadership survey found that many more pharma companies are reporting their digital strategies are ineffective compared to other industries. Heath Jackson looks at why this is – and what they need to do about it.
Jul 19, 2017
Pharmaceutical Executive
Excitement over more new treatments for cancer and rare diseases is offset by cringing over prices.
Jul 18, 2017
The Association of the British Pharmaceutical Industry is seeking permission for a Judicial Review of NICE's affordability proposals. Leela Barham reports.
Jul 17, 2017
Pharmaceutical Executive
While it’s easy to get excited about new gadgets, remember that the overall goal of mHealth and social media must be to deepen relationships and communication.
Jul 14, 2017
With the US Institute for Clinical and Economic Review (ICER) looking like it is here to stay, Leela Barham reviews its value framework.
Jul 13, 2017
In the second of her articles on value assessment, Leela Barham discusses the emergence of multiple frameworks in the US and considers their impact.
Jul 11, 2017
Maiko Midena discusses the key fundamentals to success when it comes to forecasting with large multinational pharmaceutical organizations.
Jul 10, 2017
Just as internal company compliance regulation needs to change, so too does compliance education, writes Dr. Nick Broughton.
lorem ipsum